Effects of the cannabinoid CB1receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal

  • Beardsley P
  • Martin B
  • 2

    Readers

    Mendeley users who have this article in their library.
  • 30

    Citations

    Citations of this article.

Abstract

Rats were trained to lever press according to variable interval 10 s schedules during daily experimental sessions composed of six 3 min food reinforcement periods and were treated twice daily for 6 days with either vehicle or escalating regimens of Δ9-tetrahydrocannabinol. On days 7 and 8, the rats were challenged with vehicle and cumulative doses of SR141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4,-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide hydrochloride), a cannabinoid CB1receptor antagonist, up to 3 and 9 mg/kg, respectively. Response rates increased during Δ9-tetrahydrocannabinol withdrawal and towards those of the vehicle treatment group suggesting a waning of the direct effects of Δ9-tetrahydrocannabinol. SR141716A reduced response rates but only in rats pre-treated with Δ9-tetrahydrocannabinol. These data suggest that dependence upon Δ9-tetrahydrocannabinol was induced and SR141716A precipitated withdrawal. Copyright (C) 2000 Elsevier Science B.V.

Author-supplied keywords

  • (Rat)
  • Behavioral dependence
  • Dependence
  • Operant behavior
  • SR141716A
  • THC (tetrahydrocannabinol)
  • Withdrawal

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Patrick M. Beardsley

  • Billy R. Martin

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free